RxSight, Inc.

NASDAQ:RXST

33.66 (USD) • At close December 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019
Operating Activities:
Net Income -48.608-66.756-48.68827.575126.22
Depreciation & Amortization 4.2434.0223.9884.0123.93
Deferred Income Tax 00-5.398-63.2120
Stock Based Compensation 15.74611.3977.5754.1854.598
Change In Working Capital -9.072-7.412-2.678-7.848-3.971
Accounts Receivables -9.325-6.094-1.996-2.076-0.789
Inventory -2.749-7.555-2.111-1.307-5.471
Accounts Payables 1.250.6350.555-0.9541.133
Other Working Capital 1.7525.6020.874-3.5111.156
Other Non Cash Items -3.902-0.1010.4930.085-171.396
Operating Cash Flow -41.593-58.85-44.708-35.203-40.619
Investing Activities:
Investments In Property Plant And Equipment -4.814-2.393-1.94-2.539-4.086
Acquisitions Net 17.315-42.34379.9670.0030.603
Purchases Of Investments -272.315-212.657-159.967-97.873-132.387
Sales Maturities Of Investments 25525580116130
Other Investing Activites -17.31542.343-79.96718.13-1.784
Investing Cash Flow -22.12939.95-81.90715.591-5.87
Financing Activities:
Debt Repayment -40.153-0.12114.97324.858-0.185
Common Stock Issued 105.9577.828121.1361.0151.591
Common Stock Repurchased 00000
Dividends Paid 00000
Other Financing Activities -4.28-1.3751.2330.3791.515
Financing Cash Flow 61.5246.332137.34225.2371.33
Other Information:
Effect Of Forex Changes On Cash 0.006-0.009-0.0100.005
Net Change In Cash -2.192-12.57710.7175.625-45.154
Cash At End Of Period 10.40312.59525.17214.4558.83